MBNL2 and myotonic dystrophy type 1: The effects on MuSCs and myogenic differentiation in DM1 and various mouse and cell models of RNA toxicity are clearly different from those seen in mice with MBNL1, MBNL2, or combined MBNL1 loss/MBNL2 deficiency.